Downer, E.J., Clifford E., Gran, B., Nel, H.J., Fallon, P.G. and Moynagh, P.N.
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis.